Infectious Diseases Clinical Trial 2007-021

[LCID Study Number: 2007-021]

Treatment Of Leishmaniasis With IV Pentostam (Sodium Stibogluconate)

The purpose of this study is to use Pentostam for the treatment of Leishmaniasis.

Disease/Condition: Leishmaniasis

Department: Infectious Disease

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

Protocol #: 2007-021
Principal Investigator(s): Winnie W Ooi
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Expanded Access